Dang Francis Wang, Chen Li, Madura Kiran
From the Department of Pharmacology, Robert Wood Johnson Medical School-Rutgers University, Piscataway, New Jersey 08854.
From the Department of Pharmacology, Robert Wood Johnson Medical School-Rutgers University, Piscataway, New Jersey 08854
J Biol Chem. 2016 Sep 2;291(36):18765-77. doi: 10.1074/jbc.M115.712406. Epub 2016 Jul 14.
The ubiquitin/proteasome pathway is a well characterized system for degrading intracellular proteins, although many aspects remain poorly understood. There is, for instance, a conspicuous lack of understanding of the site(s) where nuclear proteins are degraded because the subcellular distribution of peptidase activity has not been investigated systematically. Although nuclear proteins could be degraded by importing proteasomes into the nucleus, it is also evident that some nuclear proteins are degraded only after export to cytosolic proteasomes. Proteasomes and substrates are mobile, and consequently, the sites of degradation might not be static. We sought to identify the location of proteasomes to provide more conclusive evidence on the sites of protein degradation. We report that catalytically active proteasomes exist almost exclusively in the cytosol. The resulting lack of nuclear peptidase activity suggests that little, if any, degradation occurs in the nucleus. These and other studies suggest that the export of proteolytic substrates could define an important regulatory step in the degradation of nuclear proteins by cytosolic proteasomes.
泛素/蛋白酶体途径是一个已得到充分表征的用于降解细胞内蛋白质的系统,尽管许多方面仍知之甚少。例如,由于尚未系统研究肽酶活性的亚细胞分布,因此对核蛋白降解位点的了解明显不足。虽然核蛋白可以通过将蛋白酶体导入细胞核来降解,但也很明显,一些核蛋白只有在输出到胞质蛋白酶体后才会被降解。蛋白酶体和底物是可移动的,因此,降解位点可能不是固定不变的。我们试图确定蛋白酶体的位置,以提供关于蛋白质降解位点更确凿的证据。我们报告,具有催化活性的蛋白酶体几乎只存在于胞质溶胶中。由此导致的核肽酶活性的缺乏表明,细胞核中几乎不发生降解(如果有降解发生的话也极少)。这些研究以及其他研究表明,蛋白水解底物的输出可能是胞质蛋白酶体降解核蛋白过程中的一个重要调控步骤。